rs669293

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_032935.3(MT4):​c.98-401T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.212 in 151,742 control chromosomes in the GnomAD database, including 3,831 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.21 ( 3831 hom., cov: 29)

Consequence

MT4
NM_032935.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.01

Publications

3 publications found
Variant links:
Genes affected
MT4 (HGNC:18705): (metallothionein 4) Predicted to enable metal ion binding activity. Predicted to be involved in cellular response to metal ion; cellular zinc ion homeostasis; and detoxification of copper ion. Predicted to act upstream of or within cellular metal ion homeostasis. Predicted to be active in cytoplasm and nucleus. [provided by Alliance of Genome Resources, Apr 2022]
BBS2 (HGNC:967): (Bardet-Biedl syndrome 2) This gene is a member of the Bardet-Biedl syndrome (BBS) gene family. Bardet-Biedl syndrome is an autosomal recessive disorder characterized by severe pigmentary retinopathy, obesity, polydactyly, renal malformation and cognitive disability. The proteins encoded by BBS gene family members are structurally diverse and the similar phenotypes exhibited by mutations in BBS gene family members is likely due to their shared roles in cilia formation and function. Many BBS proteins localize to the basal bodies, ciliary axonemes, and pericentriolar regions of cells. BBS proteins may also be involved in intracellular trafficking via microtubule-related transport. The protein encoded by this gene forms a multiprotein BBSome complex with seven other BBS proteins.[provided by RefSeq, Oct 2014]
BBS2 Gene-Disease associations (from GenCC):
  • Bardet-Biedl syndrome 2
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Myriad Women’s Health
  • ciliopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • retinitis pigmentosa 74
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • retinitis pigmentosa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Bardet-Biedl syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.319 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MT4NM_032935.3 linkc.98-401T>C intron_variant Intron 2 of 2 ENST00000219162.4 NP_116324.2 P47944

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MT4ENST00000219162.4 linkc.98-401T>C intron_variant Intron 2 of 2 1 NM_032935.3 ENSP00000219162.3 P47944
BBS2ENST00000682930.1 linkc.42+2235A>G intron_variant Intron 2 of 18 ENSP00000507981.1 A0A804HKL9

Frequencies

GnomAD3 genomes
AF:
0.212
AC:
32174
AN:
151624
Hom.:
3832
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.323
Gnomad AMI
AF:
0.0582
Gnomad AMR
AF:
0.175
Gnomad ASJ
AF:
0.0939
Gnomad EAS
AF:
0.265
Gnomad SAS
AF:
0.238
Gnomad FIN
AF:
0.169
Gnomad MID
AF:
0.174
Gnomad NFE
AF:
0.163
Gnomad OTH
AF:
0.191
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.212
AC:
32218
AN:
151742
Hom.:
3831
Cov.:
29
AF XY:
0.213
AC XY:
15796
AN XY:
74142
show subpopulations
African (AFR)
AF:
0.323
AC:
13352
AN:
41312
American (AMR)
AF:
0.175
AC:
2669
AN:
15252
Ashkenazi Jewish (ASJ)
AF:
0.0939
AC:
325
AN:
3462
East Asian (EAS)
AF:
0.265
AC:
1356
AN:
5112
South Asian (SAS)
AF:
0.236
AC:
1132
AN:
4804
European-Finnish (FIN)
AF:
0.169
AC:
1784
AN:
10576
Middle Eastern (MID)
AF:
0.187
AC:
55
AN:
294
European-Non Finnish (NFE)
AF:
0.163
AC:
11083
AN:
67906
Other (OTH)
AF:
0.193
AC:
409
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1222
2444
3667
4889
6111
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
336
672
1008
1344
1680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.211
Hom.:
702
Bravo
AF:
0.217
Asia WGS
AF:
0.263
AC:
912
AN:
3474

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.052
DANN
Benign
0.50
PhyloP100
-2.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs669293; hg19: chr16-56602352; API